Skip to main content

Table 1 Subject profiles in two medical institutes

From: Hospital-based screening to detect patients with cadmium nephropathy in cadmium-polluted areas in Japan

 

Akita Rosai Hospital in Odate city

Kosaka clinic in Kosaka town

Male

Female

Male

Female

Number

15

20

6

16

Agea

79.0 (61–88)

81.0 (60–95)

83.2 (73–92)

80.3 (71–89)

Serum creatinine (mg/dL)a

1.19 (0.84–2.82)

1.13 (0.80–2.05)

1.39 (1.24–1.67)

1.00 (0.71–1.90)

Urinary α1MG (mg/g cr.)b

6.8 (2.7–63)

17 (ND-94)

20 (7.9–37)

13 (4.9–62)

Urinary β2MG (μg/g cr.)b

249 (ND-14,700)

1570 (ND-34,000)

3160 (274–8290)

815 (394–30,400)

Blood cadmium (μg/L)b

3.2 (1.7–7.6)

4.7 (3.4–11)

4.3 (2.5–6.1)

4.6 (2.2–13)

Urinary cadmium (μg/g cr.)b

2.96 (1.24–9.54)

5.47 (1.59–11.2)

2.25 (ND-4.85)

5.08 (ND-16.2)

  1. Data are presented as an arithmetic meana or medianb (minimum-maximum)
  2. α1MG α 1-microglobulin, β2MG ß2-microglobulin, ND not detected (β2MG, less than 70 μg/L as an original value; urinary cadmium, less than 1.28 ng/mL as an original value)